Cite

HARVARD Citation

    Poulsen, L. et al. (2022). Safety and effectiveness of recombinant factor XIII‐A2 in congenital factor XIII deficiency: Real‐world evidence. Research and practice in thrombosis and haemostasis. 6 (2), p. n/a. [Online]. 
  
Back to record